Insider Transactions in Q3 2023 at Cyma Bay Therapeutics, Inc. (CBAY)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Kurt Von Emster |
SELL
Open market or private sale
|
Direct |
15,921
-15.03%
|
$238,815
$15.68 P/Share
|
|
Sep 29
2023
|
Kurt Von Emster |
BUY
Exercise of conversion of derivative security
|
Direct |
15,921
+13.07%
|
$79,605
$5.0 P/Share
|
|
Sep 18
2023
|
Charles Mc Wherter President of R&D |
SELL
Open market or private sale
|
Direct |
21,746
-59.18%
|
$347,936
$16.22 P/Share
|
|
Sep 18
2023
|
Charles Mc Wherter President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
21,746
+37.18%
|
$108,730
$5.0 P/Share
|
|
Sep 15
2023
|
Daniel Menold Vice President, Finance |
SELL
Open market or private sale
|
Direct |
0
|
$0
$16.87 P/Share
|
|
Sep 15
2023
|
Daniel Menold Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
16,545
+50.0%
|
$16,545
$1.77 P/Share
|
|
Sep 15
2023
|
Paul T Quinlan General Counsel |
SELL
Open market or private sale
|
Direct |
53,000
-100.0%
|
$848,000
$16.87 P/Share
|
|
Sep 15
2023
|
Paul T Quinlan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
53,000
+50.0%
|
$106,000
$2.94 P/Share
|
|
Aug 18
2023
|
Charles Mc Wherter President of R&D |
SELL
Open market or private sale
|
Direct |
21,746
-59.18%
|
$239,206
$11.47 P/Share
|
|
Aug 18
2023
|
Charles Mc Wherter President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
21,746
+37.18%
|
$108,730
$5.0 P/Share
|
|
Aug 15
2023
|
Daniel Menold Vice President, Finance |
SELL
Open market or private sale
|
Direct |
0
|
$0
$12.03 P/Share
|
|
Aug 15
2023
|
Daniel Menold Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
15,500
+50.0%
|
$77,500
$5.53 P/Share
|
|
Aug 15
2023
|
Paul T Quinlan General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$55,000
$11.91 P/Share
|
|
Aug 15
2023
|
Paul T Quinlan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.94 P/Share
|
|
Aug 09
2023
|
Daniel Menold Vice President, Finance |
SELL
Open market or private sale
|
Direct |
20,945
-100.0%
|
$251,340
$12.35 P/Share
|
|
Aug 09
2023
|
Daniel Menold Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
20,945
+50.0%
|
$104,725
$5.0 P/Share
|
|
Jul 18
2023
|
Charles Mc Wherter President of R&D |
SELL
Open market or private sale
|
Direct |
21,749
-59.18%
|
$239,239
$11.43 P/Share
|
|
Jul 18
2023
|
Charles Mc Wherter President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
21,749
+37.18%
|
$108,745
$5.0 P/Share
|
|
Jul 14
2023
|
Paul T Quinlan General Counsel |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$55,000
$11.81 P/Share
|
|
Jul 14
2023
|
Paul T Quinlan General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.94 P/Share
|